静脉CT对比剂额外使用外部加温器对对比剂外渗及过敏样反应发生率的影响:一项前瞻性观察性病例对照研究
这项前瞻性观察性病例对照研究纳入2018年4月至2020年3月在本机构接受常规增强CT的15-80岁患者,评估将低渗对比剂(碘海醇350、碘克沙醇320、碘普罗胺300、碘帕醇300)体外加温至37°C对 Comparisons外渗和过敏样反应发生率的影响,并辅以体外实验观察黏度变化。结果显示碘海醇350加温后外渗率在流速<3.5 mL/sec时显著降低(P=0.037),过敏反应及总体对比剂相关反应显著减少(P<0.001);碘普罗胺300则无显著差异(P=0.432)。
要点
- 碘海醇350体外加温至37°C后,流速<3.5 mL/sec时外渗率显著降低(P=0.037)。
- 碘海醇350加温后过敏反应及总体对比剂相关反应显著减少(P<0.001)。
- 碘普罗胺300加温后外渗率(P=0.432)及反应发生率均无显著差异。
核心结论
- 体外加温对比剂有助于降低碘海醇350的过敏样反应和外渗发生率,但碘普罗胺300即使在低注射速率(<3.5 mL/sec)下也无显著差异。
研究设计与样本
- 前瞻性观察性病例对照研究,纳入2018年4月至2020年3月在本机构接受常规增强CT的15-80岁患者,共24,379例次增强CT;另进行体外实验以证明对比剂黏度和流体动力学随温度的变化。
诊断标准与关键数值
- 碘海醇350加温后外渗率在流速<3.5 mL/sec时显著降低(P=0.037)。
- 碘普罗胺300加温后外渗率无显著差异(P=0.432)。
- 碘海醇350加温后过敏反应及总体对比剂相关反应(排除生理性反应)显著减少(P<0.001)。
- 碘普罗胺300加温后过敏反应及总体对比剂相关反应无显著差异。
临床应用与阅片要点
- 对使用碘海醇350且流速<3.5 mL/sec的增强CT,可考虑将对比剂体外加温至37°C以降低外渗和过敏样反应风险。
- 对使用碘普罗胺300的增强CT,体外加温至37°C对降低外渗和反应发生率未见显著获益。
- 加温组温热感更常见,与体外实验显示的加温后黏度降低一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIMS: To prospectively determine whether extrinsic warming of the low-osmolality CT contrast media (Iohexol 350, Iodixanol 320, Iopromide 300, and Iopamidol 300) to 37°C prior to intravenous administration affects extravasation and allergic-like reaction rates.
MATERIALS AND METHODS: This large scale prospective case control study of adverse events included all the patients between the age group of 15-80 years undergoing routine contrast-enhanced computed tomographic (CECT) examinations from April 2018 to March 2020 at our institute. Ex vivo experiments were also performed to demonstrate change in contrast viscosity and fluid dynamics in relation to temperature.
RESULTS: A total of 24,379 CECTs were conducted during the study period. Extrinsic warming showed a significant decrease in extravasation rates for Iohexol 350 at flow rates <3.5 mL/sec (P=0.037). No significant difference was observed with Iopromide 300 (P=0.432). Overall, a significant decrease in allergic reactions and overall contrast-related reactions (excluding physiologic reactions) was noted (P<0.001), with Iohexol 350. However, no significant difference was found with Iopromide 300. The most common physiological reaction was a sense of warmth, more prevalent in the warmed group, aligning with ex-vivo experiments demonstrating decreased viscosity with contrast warming.
CONCLUSIONS: Extrinsic warming of contrast helps reduce the incidence of allergic-like reactions and extravasations for Iohexol 350, but no significant difference was noted with Iopromide 300 even at low injection rates (<3.5 mL/sec).
引用
- Mahajan A, Gupta A, Shukla S, et al. Additional use of extrinsic warmer for intravenous CT contrast media and its impact on incidence of contrast extravasations and allergic like reactions: a prospective observational case control study. Clin Radiol. 2024. PMID: 39277429. doi:10.1016/j.crad.2024.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。